Oxygen Biotherapeutics Mission & Goals

News & Events

Oxygen Biotherapeutics to Present at Wedbush 2014 Life Sciences Management Access Conference

Thursday, August 7, 2014 4:00 pm EDT

Public Company Information:

MORRISVILLE, N.C.--(BUSINESS WIRE)--Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT), a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, announced today that John Kelley, Chief Executive Officer, will present a company overview at the Wedbush 2014 Life Sciences Management Access Conference at Le Parker Meridien in New York on Wednesday, August 13, 2014, at 1:20 p.m. ET.
A live webcast of the presentation can be accessed under “Events and Presentations” in the Investors section of the Company’s website at www.oxybiomed.com. more..

Quick Links

About Oxygen Biotherapeutics Mission

The Mission of Oxygen Biotherapeutics is to develop and market specialty pharmaceutical products that address unmet needs of critical care patients, their health care providers, and the hospitals who treat these patients.